Beta Drugs fundamental analysis
2206.853.10 (-2.35%)
Last updated on 1 Sep, 2026 | 15:58 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Beta Drugs Fundamentals
P/E Ratio
60.59
P/B Ratio
9.58
Div. Yield
0
Sector P/E
41.23
Sector P/B
3.52
Sec. Div. Yield
0.51
Beta Drugs Fundamentals is currently trading with a P/E Ratio of 60.59, compared to the sector average of 41.23. Its P/B Ratio stands at 9.58, while the sector’s is 3.52. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.51%.
Beta Drugs Score Card
Price
Expensive
Growth
Poor
Quality
Good
Management
Good
On its scorecard, Beta Drugs reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in BETA
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC